Access Campaign News

Access Campaign News

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline.…
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Geneva —The international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) today welcomed new World Health Organization (WHO) treatment guidelines that recommend drug-resistant tuberculosis (DR-TB) be treated with oral drugs only, including newer, more…
Geneva - On the eve of the Board meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) called on the Board to make urgent changes to Global Fund policies and practices for…
Access to medicines: HIV and TB treatment at risk as countries gradually lose Global Fund support
The Hague — Activists interrupted the opening ceremony of the 49th Union World Conference on Lung Health in The Hague today, to call on US pharmaceutical corporation Johnson & Johnson (J&J) to cut the price of the TB drug bedaquiline in half, to ‘one dollar per day’, so that people who…
Activists interrupt TB conference opening ceremony to call on J&J to cut price of TB drug in half, to one dollar per day
The Hague — People with drug-resistant tuberculosis (DR-TB) continue to be deprived of today’s best-possible treatment in part because of high drug prices, according to a new report — DR-TB Drugs Under the Microscope — released today by Doctors Without Borders/Médecins Sans Frontières (MSF) at the…
MSF warns high prices of tuberculosis drugs restrict people´s access to best drug-resistant TB treatment
Sharonann Lynch, HIV & TB advisor for Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign, made the following statement today following the first-ever United Nations High-Level Meeting on Tuberculosis (TB): “The good news is this historic meeting happened at a time when the…
MSF response to first-ever UN tuberculosis summit
New York — As global leaders gather for the first-ever United Nations tuberculosis (TB) Summit in New York this week, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) called on governments to save more lives by scaling up TB testing and…
Global leaders must make bold commitments at first-ever UN tuberculosis summit
Gilead’s price gouging for Sofosbuvir blocks millions of people from getting treatment Munich/Paris/New York – This week in Munich, the European Patent Office is hearing a legal challenge filed by groups in 17 countries in March 2017 against an unmerited patent that allows US pharmaceutical…
MSF and groups call for end to Gilead’s unwarranted hepatitis C grug monopoly in Europe
Geneva — The international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) today welcomed the new World Health Organization (WHO) recommendations for improved treatment for people with drug-resistant tuberculosis (DR-TB), prioritising the use of several…
MSF applauds the World Health Organization’s move to recommend improved tuberculosis treatment options
Bangkok/Geneva - As the sixteen countries negotiating Regional Comprehensive Economic Partnership (RCEP) trade agreement meet in Bangkok this week for another round of closed-door negotiations, public health experts and the international medical humanitarian organization - Doctors Without…
ASEAN and India urged not to trade away people’s lives in trade agreement